Free Trial

BioLineRx (BLRX) Earnings Date, Estimates & Call Transcripts

BioLineRx logo
$0.10 +0.00 (+3.45%)
Closing price 04:00 PM Eastern
Extended Trading
$0.11 +0.00 (+0.95%)
As of 07:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BioLineRx Latest Earnings Summary

Upcoming Q4
Earnings Date
Mar. 25Before Market OpensEstimated
Actual EPS
(Nov. 25)
-$0.07 Beat By $0.01
Consensus EPS
(Nov. 25)
-$0.08

BioLineRx issued Q3 2024 earnings on November 25, 2024, reporting an EPS of -$0.07, which topped the consensus estimate of -$0.08 by $0.01. With a trailing EPS of -$0.22, BioLineRx's earnings are expected to grow next year, from ($0.15) to ($0.14) per share.

BLRX Upcoming Earnings

BioLineRx's next earnings date is estimated for Tuesday, March 25, 2025, based off prior year's reporting schedules.

Get BioLineRx Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioLineRx and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

BLRX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BLRX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

BioLineRx Analyst EPS Estimates

Current Year EPS Consensus Estimate:($0.15) EPS
Next Year EPS Consensus Estimate: ($0.14) EPS

BioLineRx Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
3/25/2025
(Estimated)
-------
11/25/2024Q3 2024-$0.08-$0.07+$0.01-$0.07--
11/25/2024Q3 2024-$0.08-$0.07+$0.01-$0.07--
8/15/2024Q2 2024-$0.08$0.01+$0.09$0.01$3.93M$5.39M
5/28/2024Q1 2024-$0.29-$0.01+$0.28-$0.01$0.34M$6.86M
3/28/2024Q4 2023-$0.22-$0.15+$0.07-$0.15$0.17M$4.80M
11/20/2023Q3 2023-$0.18-$0.30 -$0.12-$0.30--
8/30/2023Q2 2023-$0.16-$0.30 -$0.14-$0.30--
5/24/2023Q1 2023-$0.14-$0.15 -$0.01-$0.15--
3/22/2023Q4 2022-$0.14-$0.09+$0.05-$0.09--

BioLineRx Earnings - Frequently Asked Questions

BioLineRx has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 25th, 2025 based off last year's report dates. Learn more on BLRX's earnings history.

BioLineRx (NASDAQ:BLRX) has a recorded annual revenue of $4.80 million.

BioLineRx (NASDAQ:BLRX) has a recorded net income of -$60.61 million. BLRX has generated -$0.22 earnings per share over the last four quarters.

BioLineRx's earnings are expected to grow from ($0.15) per share to ($0.14) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:BLRX) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners